Sep 2013

Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis

Parasitology

by Wring S, Gaukel E, Nare B, Jacobs R, Beaudet B, Bowling T, Mercer L, Bacchi C, Yarlett N, Randolph R, Parham R, Rewerts C, Platner J and Don R. Parasitology, September 2013.

Click here to access the article

Latest scientific articles

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis

Latest scientific articles

Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort

From invisibility to political power: Policy lessons from a decade of Brazil’s Social Forum for Infectious and Neglected Diseases

In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting

Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression

Stay connected

Learn more

Get in touch

Support us

Work with us